Publications

Sort by: Date | Author | Title

Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M., D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014). A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL). Blood, 124(21).
O'Connor, O. A., Bhagat, G., Ganapathi, K., Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014). Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice. Clinical Cancer Research, 20(20), 5240-54. Article e006363. https://doi.org/10.1158/1078-0432.CCR-14-2020
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Nørgaard, P., Johansen, P., Ralfkiaer, E., Brown, P. D. N., Hansen, P. B., Jensen, B. A., Madsen, J., Schöllkopf, C. & d'Amore, F. (2014). Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry. Hematological Oncology (Online), 33(4), 120-128. https://doi.org/10.1002/hon.2153
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G., D'Amore, F. A. & Kolstad, H. (2014). Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine, 71(Suppl 1).
Petruskevicius, I., Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B. & D'Amore, F. A. (2014). Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Kilpivaara, O., Ristolainen, H., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., D'Amore, F. A. & Lauri, A. A. (2014). Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing. Blood, 121(24).
Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M., D'Amore, F., Nilsson-Ehle, H., Jensen, P., Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014). Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study. Blood, 124(8), 1288-95. https://doi.org/10.1182/blood-2014-03-559930
El-Galaly, T., Mylam, K. J., Bøgsted, M., Brown, P., Rossing, M., Gang, A. O., Haglund, A., Arboe, B., Clausen, M. R., Jensen, P., Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B., D'Amore, F. & Hutchings, M. (2014). Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. American Journal of Hematology, 89(6), 575-580. https://doi.org/10.1002/ajh.23688, https://doi.org/10.1002/ajh.23688
D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L. & Pedersen, M. B. (2014). T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up. Annals of Oncology.
Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E., d'Amore, F., Tilly, H. & Zinzani, P. L. (2014). Therapeutic options in relapsed or refractory peripheral T-cell lymphoma. Cancer Treatment Reviews, 40(9), 1080-1088. https://doi.org/10.1016/j.ctrv.2014.08.001
Vase, M. Ø., Maksten, E. F., Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Jespersen, B., Kampmann, J., Rabinovich, G. A., Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014). Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder. Poster session presented at ASH 2014 American Society of Hematology, San Francisco, United States.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA., Steiniche, T., Bang, K., Deleuran, M. & D'Amore, F. A. (2013). Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP). British Journal of Dermatology.
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013). Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Annals of Oncology, 24(3), 561-76.
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H., D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013). Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas. Blood.
Snipsøyr, M. G., Wiggers, H., Knudsen, J. B., Ludvigsen, M., Poulsen, S. H., Petersen, E. & Honoré, B. (2013). Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.
Wästerlid, T., Brown, P. D. N., Hagberg, O., Hagberg, H., Pedersen, LM., D'Amore, F. A. & Jerkeman, M. (2013). Impact of chemotherapy regimen and rituximab in adult Burkitt Lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Annals of Oncology, 24(7), 1879-1886.
D'Amore, F. A., Lauritzsen, G. F., Relander, T., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U., Gadeberg, O., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2013). Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial. Hematological Oncology, 31, 176-177.
El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M., Bukh, A., Amdi Jensen, B., Poulsen, C., D'Amore, F. A. & Hutchings, M. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology, 31.
Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L., D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013). Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study. Hematological Oncology, 31, 138.